ABSTRACT

Tracks

Introduction

The National HIV & AIDS Research Conference (NHARCON) is organized by the Ghana AIDS Commission every four years. The 2018 conference is the fourth to be organized by the Commission. NHARCON 2018 is expected to serve as a platform to share ideas in support of the implementation of the current National HIV and AIDS Strategic Plan 2016-2020. It also forms part of GAC’s mandate to disseminate and share HIV and AIDS strategic information with its stakeholders and partners in the implementation of the National Response.

2.0 Objectives

General Objective

The overall objective of NHARCON is to provide a platform for the exchange of local and global research and best practices towards achieving epidemic control in Ghana

Specific Objectives

The specific objectives of the conference are to:

  • Share knowledge and best practices for HIV interventions.
  • Disseminate findings from relevant HIV and AIDS researches undertaken in Ghana and elsewhere.
  • Provide the opportunity for researchers from around the world to share the latest scientific advances in the field, learn from one another’s expertise.
  • Review strategies for advancing the fast track 90-90-90 strategy and “Treat All” policy.
  • Discuss and identify future programme strategies and research priorities in light of evidence and best practices.
  • To provide mentorship for less experienced researchers to develop concept notes, abstracts and presentations.

The Ghana AIDS Commission, the organisers of NHARCON 2018 request for works that introduce novel ideas and/or concepts, new research findings and advances in the field.

Submit an abstract by following the guidelines provided below:

 

Tracks

The conference will have three main tracks namely:

Track A:      Social and Behavioural Sciences;

Track B:       Epidemiology, Basic and Clinical Sciences;

Track C`:     Interventions and Best Practices.

 

Each Scientific Track is divided into a number of track categories. All persons submitting abstracts are requested to choose a Scientific Track and a Track Category that best describes their subject of abstract. Accepted abstracts will be published under the general headings of these scientific tracks.

Track A: Social and Behavioural Science

A1.  Stigma and Discrimination and Impact on HIV
A2.  Sex, sexuality, gender relationships and HIV
A3.   Policies, programmes and HIV response.
A4.   Communication, mass media and popular education.
A5.   Socio-cultural determinants of HIV.
A6.    Structural determinants of HIV.
A7.    Human rights, law and ethics.
A8.    Sex Work: Behavioural, Social and Cultural Issues and Contexts
A9.   Living with HIV and AIDS
A10.  Ethics and Human Rights
A11. Adolescents, young people and relationships
A12. Fertility, family planning, reproductive health services and HIV
A13. Policy development, implementation and evaluation
A14. Violence, conflict and Humanitarian disasters and HIV
A15. Prisons, closed settings and HIV
A16. Family-centered approach to HIV care and support
A17. Poverty, wealth, income inequalities and HIV
A18. Illicit drug use policies, harm reduction and socio-cultural factors

 

Track B:  Epidemiology, Basic and Clinical Science

B1.  HIV evolution, viral diversity and bioinformatics
B2.  HIV co-infections and emerging pathogens
B3.  Interaction of micronutrients, nutrition and HIV infection
B4.  Clinical Course of HIV infection and disease
B5.  HIV and Non Communicable Diseases (NCD)
B6.  Immunology of HIV
B7.  Antiretroviral Therapy
B8.  HIV and AIDS Surveillance, Monitoring and Evaluation
B9.  HIV and AIDS Prevention Programmes
B10. Diagnostic and Monitoring Tools
B11. Co-Morbidities and Complications (including those related to ART)
B12. Other Strategies and Therapies (non-ART)
B13. Specific Issues Related to HIV Infection in Women
B14. Specific Issues Related to HIV Infection in Infants, Children and Adolescents
B15. Specific Issues Related to HIV Infection and Treatment in Key Populations

 

Track C:  Interventions and Best Practices

C1. Antiretroviral therapy

C1.1 First line therapy (when to start, what to start with, durability)
C1.2 Treatment failure: drug resistance, second line therapy and salvage therapy
C1.3 Adherence and retention
C1.4 Antiretroviral therapy in children
C1.5 HIV management in adolescents
C1.6 Antiretroviral therapy in pregnant women
C1.7 Antiretroviral therapy in elder populations
C1.8 Management of HIV infection in Key Populations
C1.9 Antiretroviral therapy to prevent HIV-Transmission– Diversified prevention tools: PeP PrEP TAsP Microbicides
C1.10 Treat all

 

C2. Palliative care and nutrition

C2.1 Pain management and end of life care
C2.2 Clinical nutritional care in HIV infection
C2.3 Home and community based care and support
C2.4 Other Strategies and Therapies (traditional medicine, spiritual care)

 

C3. Policies, Programs, guidelines and HIV response

C3.1 Country adaptation of global HIV diagnosis and treatment guidelines
C3.2 Diagnosis and monitoring tools
C3.3 Harm reduction policies and politics
C3.4 HIV policies and the workplace
C3.5 HIV policies and educational institutions

 

C4. Innovation and best practices

C4.1 Interventions at scale (community, district, provincial, regional, country levels) to increase uptake of and retention in HIV services
C4.2 Partnership involving donors, NGOs and government
C4.3 Effects of public-private partnerships, including workplace programmes and policies
C4.4 Innovating HIV response with new technologies
C4.5 Working with community-led organizations, including key populations, faith-based groups, traditional healer organizations, and with community leaders
C4.6 Differentiated Models of Care and Service Delivery
C4.7 Non-ARV Based Interventions to Combat HIV/AIDS
C4.8 mHealth and the Global HIV Response

 

C5. Integration of HIV Services with Other Programmes – best practices

C5.1 Integration of HIV services with other health programmes
C5.2 Integration of HIV and HCV services
C5.3 Integration of HIV services with other development programmes
C5.4 Integration of prevention interventions with care/treatment

C6.Diagnostics – best practices

C.1 Scale up of paediatric diagnosis
C6.2 Scale up of point-of-care technologies
C6.3 Scale up of viral load monitoring
C6.4 Optimal split between laboratory-based and point-of-care devices

C7. Monitoring and Evaluation – best practices

C7.1 Monitoring and evaluation of prevention
C7.1 Monitoring and evaluation of testing
C7.2 Monitoring and evaluation of treatment and care
C7.3 Monitoring and evaluation of HIV cascade
C7.4 Monitoring and evaluation of health systems

C8. Implementation Science

C8.1 Operational challenges in implementing HIV services
C8.2 Adherence to HIV treatment
C8.3 Uptake of HIV services
C8.4 Retention in HIV services
C8.5 Linkage between HIV services
C8.6 Differentiated models of care
C8.7 Combination interventions that span prevention / screening / treatment